NVO
Novo Nordisk A/S
NVO has a slight edge over WGS overall, supported by stronger fundamentals and lower modeled downside.
WGS
GeneDx Holdings Corp.
WGS offers stronger modeled upside, but that advantage does not outweigh its weaker overall profile.
NVO Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Stable | |
| Healthy |
NVO's revenue, profitability and balance sheet are currently healthy, and its cash flow is stable.
WGS Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Weak | |
| Weak | |
| Strong |
WGS's balance sheet is currently strong, and its revenue is stable, but its profitability and cash flow are weak.
NVO PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 10x | $40.65 | — |
| Cheap | 14x | $53.56 | +32% |
| Fair | 27x | $103 | +154% |
| Expensive | 39x | $152 | +273% |
Historical ranges are pointers, not guarantees.
NVO's PE is 10x, but its earnings don't support one, so it isn't a reliable read right now.
WGS PE Valuation
WGS has no meaningful PE right now: it lost money over the past year. If it returns to profit as analysts expect, today's price would be 59x next year's earnings.
NVO Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Stable | |
| Growth | |
| Weakening | |
| Limited | |
| Low |
Analysts expect NVO's revenue to grow, but its profitability to weaken. However, they disagree widely on these estimates.
WGS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Returning to profit | |
| Growth | |
| Strongly improving | |
| Limited | |
| High |
WGS has the edge over NVO on the outlook, with more favorable earnings and profitability expectations.
NVO Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | $3.89 | +4.9% |
| Q1 2026 | $4.07 | +17% |
| Q4 2025 | $3.42 | +1.8% |
| Q3 2025 | $3.47 | +10% |
| Q2 2025 | $3.71 | +24% |
| Q1 2025 | $3.49 | +18% |
| Q4 2024 | $3.36 | +21% |
| Q3 2024 | $3.15 | +27% |
NVO has the edge over WGS on earnings quality, reporting a profit while its opponent remains loss making.
WGS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.88 | — |
| Q3 2026 | -$3.76 | -3518% |
| Q2 2026 | -$3.62 | -5271% |
| Q1 2026 | -$2.66 | -$1.27 |
| Q4 2025 | -$0.73 | +$1.21 |
| Q3 2025 | $0.11 | +$3.01 |
| Q2 2025 | $0.07 | +$4.30 |
| Q1 2025 | -$1.39 | +$3.58 |
| Q4 2024 | -$1.94 | +$5.29 |
WGS has swung to a loss: it lost $3.76 per share over the past year, after a profit the year before.
NVO Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $11.7B | +2.1% |
| Q1 2026 | $14.4B | +24% |
| Q4 2025 | $11.8B | -7.6% |
| Q3 2025 | $11.1B | +5.1% |
| Q2 2025 | $11.4B | +13% |
| Q1 2025 | $11.6B | +19% |
| Q4 2024 | $12.7B | +30% |
| Q3 2024 | $10.6B | +21% |
NVO's revenue is growing: $11.7B last quarter, up 2.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 34% | -9 points |
| Q1 2026 | 62% | +12 points |
| Q4 2025 | 40% | -2.8 points |
| Q3 2025 | 32% | -16 points |
| Q2 2025 | 44% | +5.4 points |
| Q1 2025 | 50% | +1 points |
| Q4 2024 | 43% | +2.2 points |
| Q3 2024 | 47% | +1.6 points |
NVO has the edge over WGS on profitability, with a higher operating margin.
WGS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $123.1M | +5.4% |
| Q2 2026 | $114.4M | +11% |
| Q1 2026 | $102.3M | +17% |
| Q4 2025 | $121M | +27% |
| Q3 2025 | $116.7M | +52% |
| Q2 2025 | $102.7M | +46% |
| Q1 2025 | $87.1M | +40% |
| Q4 2024 | $95.6M | +67% |
WGS has the edge over NVO on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -8.5% | -5.7 points |
| Q2 2026 | -15% | -24 points |
| Q1 2026 | -56% | -51 points |
| Q4 2025 | -12% | -21 points |
| Q3 2025 | -2.8% | +7.3 points |
| Q2 2025 | 8.7% | +24 points |
| Q1 2025 | -5.2% | +17 points |
| Q4 2024 | 9.2% | +54 points |
WGS's operating margin was −8.5% last quarter, down 5.7 points from the same quarter a year ago.
NVO Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $6.3B | +73% |
| Q1 2026 | $1.8B | +20% |
| Q4 2025 | -$5.4B | -$4.7B |
| Q3 2025 | $4.6B | -2.1% |
| Q2 2025 | $3.6B | -34% |
| Q1 2025 | $1.5B | +89% |
| Q4 2024 | -$632.6M | +$390.5M |
| Q3 2024 | $4.7B | +3.3% |
NVO has the edge over WGS on cash generation, producing positive trailing cash flow while its opponent burns cash.
WGS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$15.8M | -265% |
| Q2 2026 | -$39.1M | -586% |
| Q1 2026 | -$38.9M | -1059% |
| Q4 2025 | -$7.4M | -$1.2M |
| Q3 2025 | $9.6M | +$14.6M |
| Q2 2025 | $8.1M | +$13.9M |
| Q1 2025 | $4.1M | +$20.9M |
| Q4 2024 | -$6.2M | +$26M |
WGS has burned cash in almost every quarter: −$101M over the past year, against $15M the year before.
NVO Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.3% | -12.9M shares |
| 1 year | -0.2% | -11M shares |
| 3 years | -1.5% | -66.8M shares |
| 5 years | -3.8% | -177M shares |
| Available history | -6.5% | -311M shares |
NVO has the edge over WGS on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2026 | $520M |
| Q1 2026 | $356.7M |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | $206.3M |
| Q4 2024 | $1.1B |
| Q3 2024 | $357.4M |
NVO spent $877M buying back its own shares over the past year, down 48% from the year before.
WGS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.6% | +170K shares |
| 1 year | +3.8% | +1.1M shares |
| 3 years | +16% | +4.1M shares |
WGS has 30M diluted shares, up 3.8% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | — |
NVO Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.7x | Very low |
| Q4 2025 | 0.6x | Very low |
| Q3 2025 | 0.4x | Very low |
| Q2 2025 | 0.5x | Very low |
| Q1 2025 | 0.5x | Very low |
| Q4 2024 | 0.6x | Very low |
| Q3 2024 | -0.0x | Very low |
NVO's net debt is less than a year of its operating earnings (EBITDA).
WGS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2025 | -2.3x | Net Cash |
| Q2 2025 | -1.5x | Net Cash |
WGS has more cash than debt.
NVO Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 43.0 | Neutral |
| Stochastic | 27.0 | Neutral |
NVO's weekly RSI is 43 (neutral) and its Stochastic is 27 (neutral).
WGS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 39.6 | Neutral |
| Stochastic | 14.6 | Oversold |
WGS's weekly RSI is 40 (neutral) and its Stochastic is 15 (oversold).
NVO PE vs Healthcare Sector
| Metric | NVO | Sector median | Relative |
|---|---|---|---|
| PE | 10x | 26x | 60% below |
| PE % | 6 | 29 | 23 pts below |
NVO is trading at 10x earnings, a 60% discount to the Healthcare sector's median of 26x, though its earnings don't support one.
WGS PE vs Healthcare Sector
| Metric | WGS | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
WGS has no meaningful PE right now: it lost money over the past year.
NVO Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $39.2 | 3.7% above |
| 20 week MA | $43.9 | 7.4% below |
| 50 week MA | $45.3 | 10% below |
| 100 week MA | $56.3 | 28% below |
| 200 week MA | $80.7 | 50% below |
NVO has the edge over WGS on trend strength, trading above more of its moving averages.
WGS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $66.5 | 22% below |
| 20 week MA | $72.7 | 29% below |
| 50 week MA | $79.8 | 35% below |
| 100 week MA | $89.1 | 42% below |
| 200 week MA | $54.0 | 4% below |
WGS is in a downtrend: it's below all five of its weekly moving averages, and 4% below its 200-week average.
NVO Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $29.1 | $34.7 | +19% |
| 2021 | $34.7 | $54.2 | +56% |
| 2022 | $54.2 | $67.0 | +24% |
| 2023 | $67.0 | $103.5 | +54% |
| 2024 | $103.5 | $87.4 | -16% |
| 2025 | $87.4 | $52.4 | -40% |
| 2026 YTD | $52.4 | $40.7 | -22% |
NVO has the edge over WGS on returns for 2026, with the stronger performance.
WGS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $323.4 | $382.5 | +18% |
| 2021 | $382.5 | $154.1 | -60% |
| 2022 | $154.1 | $8.02 | -95% |
| 2023 | $8.02 | $2.75 | -66% |
| 2024 | $2.75 | $78.1 | +2738% |
| 2025 | $78.1 | $133.8 | +71% |
| 2026 YTD | $133.8 | $51.9 | -61% |
WGS's yearly returns have swung widely, from +2738% in 2024 to −95% in 2022. It's down 61% so far in 2026.